More on AXSM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $232.32 |
|
|||
| Open | $234.00 | ||||
| 52 Wk High | $15.74 | ||||
| 52 Wk Low | $5.37 | ||||
| Day High | $239.22 | ||||
| Day Low | $233.29 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 146,074 | ||||
- Morgan Stanley tracks prescription trends for US neurology drugs
- Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting
- H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM)
- Form 8-K Axsome Therapeutics, For: Jun 03
- Axsome settles SUNOSI patent litigation, allows generics starting 2040
- Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation
- Form 4 Axsome Therapeutics, For: May 29 Filed by: Coleman Mark
- Form 144 Axsome Therapeutics, Filed by: Coleman Mark
- Form 144 Axsome Therapeutics, Filed by: Coleman Mark
- Axsome partners with Headache Alliance for migraine awareness month
Entities mentioned with AXSM
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
